Development and commercialisation licence SRA737 | 02-Jan-2024 | 07:00 | RNS |
Results of AGM | 14-Dec-2023 | 15:35 | RNS |
Annual General Meeting Statement | 14-Dec-2023 | 07:00 | RNS |
Drawdown of Equity Prepayment Facility | 23-Nov-2023 | 07:00 | RNS |
Notice of AGM, Annual Report and Accounts | 21-Nov-2023 | 07:00 | RNS |
Initiation of food effects study for SDC-1801 | 09-Nov-2023 | 07:00 | RNS |
Director Dealings | 08-Nov-2023 | 15:03 | RNS |
Sareum enhances SDC-1801 patent protection | 03-Nov-2023 | 07:05 | RNS |
Exercise of Share Options and Director Dealings | 02-Nov-2023 | 14:48 | RNS |
Final Results for the Year Ended 30 June 2023 | 09-Oct-2023 | 07:00 | RNS |
Notice of Results and Investor Presentation | 03-Oct-2023 | 07:00 | RNS |
Director's Dealing | 06-Sep-2023 | 07:00 | RNS |
Director Dealing | 05-Sep-2023 | 07:00 | RNS |
Dosing of first subjects in MAD Phase 1a trial | 04-Sep-2023 | 07:00 | RNS |
Update on financial and operational progress | 16-Aug-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 43.50p |
Change Today | 3.00p |
% Change | 7.41 % |
52 Week High | 135.00 |
52 Week Low | 10.25 |
Volume | 781,084 |
Shares Issued | 106.84m |
Market Cap | £46.47m |
RiskGrade | 594 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
15:30 | 60,000 @ 44.00p |
15:35 | 40,000 @ 44.00p |
16:26 | 20,000 @ 43.00p |
16:25 | 500 @ 43.00p |
16:23 | 8,895 @ 43.10p |
You are here: research